1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Metaneb?

Discussion in 'Hill-Rom' started by anonymous, Jan 4, 2016 at 9:07 PM.

  1. anonymous

    anonymous Guest

    got a call from a recruiter today about a sales spot selling metaneb. Any info on product, manager, company?
     
  2. anonymous

    anonymous Guest

    decent product, horrible sales management (big brother), low growth company that use acquisitions to obscure their poor organic performance and ineptitude.